New York, NY -- (SBWIRE) -- 01/22/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: ZipRealty, Inc (NASDAQ:ZIPR), Cowen Group Inc (NASDAQ:COWN), Progenics Pharmaceuticals, Inc (NASDAQ:PGNX), Timberline Resources Corp (NYSEMKT:TLR)
ZipRealty, Inc (NASDAQ:ZIPR) showed a volume of 1.35 million shares by the end of last trade whereas the average volume of the stock remained 28,254 shares. The stock opened the session at $6.05 but then moved to $4.89. At that price, the stock showed a negative performance of -25.46%. ZipRealty, Inc., is a provider of technology and online marketing capabilities in the residential real estate brokerage industry. The Company offers Internet-enabled, technology and access to information that real estate professionals can combine with their own local knowledge and personal knowledge to offer an start-to-finish experience to their clients.
Will ZIPR Get Buyers Even After The Recent Rally? Find Out Here
Cowen Group Inc (NASDAQ:COWN) opened the session at $4.05 and closed the session at $4.35. The stock showed a positive performance of 7.94% in previous trading session. Cowen Group, Inc. (Cowen Group) together with its subsidiaries, provides alternative investment management, investment banking, research, and sales and trading services through its two business segments: Ramius LLC and its affiliates (Ramius) consists of the Company's alternative investment management segment,
For How Long COWN will fight for Profitability? Read This Trend Analysis report
Progenics Pharmaceuticals, Inc (NASDAQ:PGNX) opened the session at $7.12 and closed the session at $6.93. The stock showed a negative performance of -1.56% in previous trading session. The beta of the stock remained 1.24. Progenics Pharmaceuticals, Inc. (Progenics) is a biopharmaceutical company focuses on research and development for biotechnology product candidates in oncology, virology, supportive care and gastroenterology. It is also engaged in research to identify multiplex phosphoinositide 3-kinase inhibitors for blocking signaling pathways in the growth of aggressive cancers.
Why Should Investors Buy PGNX After the Recent Fall? Just Go Here and Find Out
Timberline Resources Corp (NYSEMKT:TLR) the stock advanced 42.77% and finished the session at $0.230. Traded with volume of 1.34 million shares in the prior session and the average volume of the stock remained 132,915.00 shares. The beta of the stock remained 1.71. Timberline Resources Corporation (Timberline) is an exploration-stage company. The Company is engaged in evaluating, acquiring and exploring mineral prospects with potential for economic deposits of precious and base metals.
Will TLR Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)